Search for: "Watson Pharma"
Results 61 - 80
of 184
Sort by Relevance
|
Sort by Date
3 Jan 2012, 2:10 am
This one is made by Watson Pharmaceuticals. [read post]
7 Dec 2011, 6:38 am
Scenario #1: Brand Name Kadian® 300mg per day 100mg capsule (manufactured by Actavis, NDC 46987-0324-11) with AWP of $21.1193 per capsule Annual cost of regimen = $22,808.84 Cost of regimen over claimant’s life expectancy = $684,265.20 Scenario #2: Conversion to Generic Morphine Sulfate Extended-Release 300mg per day 100mg capsule (manufactured by Watson Pharma, NDC 00591-3453-01) with AWP of $18.2471 per capsule Annual cost of regimen = $19,706.87… [read post]
4 Dec 2011, 8:52 pm
– Florida; Watson Pharma, Inc. [read post]
3 Nov 2011, 9:55 am
Watson Pharmaceuticals, Inc., 629 F. [read post]
2 Nov 2011, 2:00 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
20 Oct 2011, 11:46 pm
A year ago, Gardephe also dismissed a claim made by Bayer against Sandoz and Watson Pharma, both of which were trying to make a generic version of Yasmin. [read post]
19 Oct 2011, 3:30 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
12 Oct 2011, 3:46 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Oct 2011, 9:37 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Laboratories Inc. - Florida Infringement of U.S. [read post]
5 Oct 2011, 3:44 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
5 Oct 2011, 3:44 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
30 Sep 2011, 2:32 pm
[3] Geneva Pharma. [read post]
25 Aug 2011, 10:55 am
By James DeGiulio -- Allergan Secures Infringement Ruling Against Generics in Combigan Patent Suit Allergan has successfully secured an infringement ruling against Sandoz, Alcon, Apotex, and Watson Laboratories in the consolidated patent suit over four patents covering the glaucoma medication Combigan. [read post]
24 Aug 2011, 12:03 pm
Barr Pharmaceuticals settled a similar case last year and Watson/Schein Pharmaceuticals Inc. reportedly anticipates an imminent settlement. [read post]
27 Jul 2011, 1:01 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
20 Jul 2011, 4:04 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
17 Jul 2011, 9:17 pm
– Florida; Watson Pharma Inc. [read post]
13 Jul 2011, 3:04 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
10 Jul 2011, 9:20 pm
– Florida; Watson Pharma, Inc. [read post]
6 Jul 2011, 2:21 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
